We have previously introduced the cycleave PCR technique as applicable to the routine screening of KRAS/BRAF mutations in CRC from pathological specimens, such as surgical and biopsy specimens (Yokota et al, 2010). This evidence concerns the gene KRAS and colorectal carcinoma.